The ripe purple berries of the native Indian plant, Eugenia jambolana Lam., known as Jamun, are popularly consumed and available in the United States in Florida and Hawaii. Despite the growing body of data on the chemopreventive potential of edible berry extracts, there is paucity of such data for Jamun fruit. Therefore our laboratory initiated the current study with the following objectives:1) to prepare a standardized Jamun fruit extract (JFE) for biological studies and, 2) to investigate the anti-proliferative and pro-apoptotic effects of JFE in estrogen dependent/aromatase positive (MCF-7aro), and estrogen independent (MDA-MB-231) breast cancer cells, and in a normal/nontumorigenic (MCF-10A) breast cell line. JFE was standardized to anthocyanin content using the pH differential method, and individual anthocyanins were identified by high performance liquid chromatography with ultraviolet (HPLC-UV) and tandem mass spectrometry (LC-MS/MS) methods. JFE contained 3.5% anthocyanins (as cyanidin-3-glucoside equivalents) which occur as diglucosides of five anthocyanidins/aglycons: delphinidin, cyanidin, petunidin, peonidin and malvidin. In the proliferation assay, JFE was most effective against MCF-7aro (IC 50 =27 µg/mL), followed by MDA-MB-231 (IC 50 =40 µg/mL) breast cancer cells. Importantly, JFE exhibited only mild antiproliferative effects against the normal MCF-10A (IC 50 >100 µg/mL) breast cells. Similarly, JFE (at 200 µg/mL) exhibited pro-apoptotic effects against the MCF-7aro (p≤0.05) and the MDA-MB-231 (p≤0.01) breast cancer cells, but not towards the normal MCF-10A breast cells. These studies suggest that JFE may have potential beneficial effects against breast cancer.
INTRODUCTION
Breast cancer is a leading cause of cancer-related deaths in the United States and is estimated to kill more than 400,000 women and 400 men for the year 2007 alone (1) . In fact, breast cancer accounts for more than 1 in 4 cancers diagnosed in women in the United States. Reproductive hormones, such as estrogen, are thought to influence breast cancer risk through effects on cell proliferation and DNA damage as well as promotion of cancer growth. Early menarche (<12 years), older age at menopause (>55 years), older age at first full-term pregnancy (>30 years), and fewer number of pregnancies may increase a woman's risk of breast cancer by affecting the levels of reproductive hormones produced by her body (1) .
Although pharmaceutical agents have a therapeutic role in breast cancer, there is emerging evidence on the preventive role of plant extracts including dietary agents. For example, previous studies have shown that white button mushrooms (Agaricus bisporous) exhibit breast cancer chemopreventive ability through suppression of aromatase, the enzyme responsible for estrogen synthesis (2) . Other foods, such as pomegranate (Punica granatum), have also been shown to be effective against breast cancer through the inhibition of aromatase activity (3) . Because a large percentage of both pre-and post-menopausal patients have estrogen-dependent carcinomas, the suppression of estrogen formation by using dietary agents capable of acting as aromatase inhibitors, may offer a useful prevention strategy in these high risk individuals.
The native Indian tree, Eugenia jambolana Lam. (syn. Syzygium cuminii Skeels; Eugenia cuminii Druce.; Family: Myrtaceae), is found widely in the Asian sub-continent and other tropical regions of the world including South America and Madagascar. In the United States, E. jambolana is found in Florida and Hawaii (USDA Natural Resource Conservation Service Plant Database). When ripened, the edible fruits of E. jambolana, known as Jamun or Jambul (in India), Jambolão (in Brazil), and Java plum (in the United States), are deep purple oblong berries similar in appearance to a purple grape but with a large centrally located pit (picture shown in Figure 1 ). The pulp of the Jamun berry contains the anthocyanins, delphinidin, petunidin and malvidin-diglucosides, which impart its bright purple color (4, 5) . Both the fruit pulp and seed extracts of the Jamun berry have a long history of medicinal use and they have been extensively studied for their anti-diabetic properties (recently reviewed in 6). Despite a growing body of evidence supporting the anticancer properties of anthocyanin-rich berry extracts (reviewed in 7), there is paucity of data on Jamun berries. Therefore our laboratory initiated the current study with the following objectives: 1) to prepare a standardized Jamun fruit extract (JFE), enriched in anthocyanins, for biological studies and, 2) to investigate JFE for in vitro anti-proliferative and pro-apoptotic effects in breast cancer (MCF7aro and MDA-MB-231) and normal breast (MCF10A) cells. The MCF-7aro breast cancer cells are estrogen receptor (ER) positive/aromatase positive cells and the MDA-MB-231 are triple negative [lacking expression of ER, PR (progesterone receptor) and human epidermal growth factor receptor 2 (HER-2)].
MATERIALS AND METHODS

Reagents
All solvents were either analar or HPLC grade and purchased Wilkem Scientific Co. (Pawtucket, RI). The XAD-16 resin (Amberlite) was obtained from Sigma-Aldrich (Saint Louis, MO).
Preparation of Jamun Fruit Extract (JFE)
Freeze-dried Jamun pulp powder (500 g) obtained from fruits collected in Gujarat, India was kindly provided by Verdure Sciences (Noblesville, IN). The identification of Eugenia jambolana Lam. (syn. Syzigium cumini L. Skeels) fruit was authenticated by matching the macroscopic and microscopic characteristics of the plant parts to internal monograph and botanical reference standards and botanically authenticated specimens have been deposited at Verdure Sciences. The Jamun fruit extract was enriched in anthocyanins and prepared according to previously published methods with slight modifications (8, 9) . Briefly, a portion of the freeze-dried whole fruit powder (260 g) was sequentially and exhaustively extracted with cold hexanes, followed by ethyl acetate, then acidified methanol (0.1% hydrochloric acid).
The solvents were removed in vacuo using a rotary evaporator, with water bath temperature at 35 °C, to yield dried hexanes (1.1 g; pale green color), ethyl acetate (2.0 g; green-brown color) and methanol (100.0 g; dark red-purple color) extracts. Based on a combination of visual appearance for red-purple coloration (indicating the presence of anthocyanins), and HPLC analysis by monitoring at 530 nm (the characteristic absorbing wavelength of anthocyanins), the methanol extract was selected for further purification. The extract (100.0 g) was reconstituted in water and enriched in anthocyanin content by using adsorption chromatography on an XAD-16 Amberlite resin column. The extract was adsorbed onto the resin and eluted with water (5 L) to remove sugars and acids that are naturally found in the fruit. The column was then eluted with acidic methanol (0.1% hydrochloric acid) to afford a red-purple Jamun fruit extract (JFE, 16.0 g) after solvent removal as described above.
Anthocyanin Content of JFE
The anthocyanin content was determined by using the pH differential method and was calculated as equivalents of cyanidin-3-glucoside, using the extinction coefficient of 26900 L cm −1 mg −1 and a molecular mass of 449.2 g/L as previously reported (10) . Briefly, an accurately weighed sample of the extract was used to make a stock solution in a 100 mL volumetric flask. Two aliquots of this stock solution (1.0 mL each) were removed and placed into separate 25 mL volumetric flasks which where made up to mark with pre-prepared buffers of pH 1.0 or pH 4.5, respectively. Absorbance of these two buffer solutions were recorded at 510 nm using a spectrophotometer (Spectramax M2, Molecular Devices, operated by SoftmaxPro v.4.6 software). According to this assay protocol, absorbance can also be recorded at 700 nm if there is sample turbidity. The difference in absorbance between the two samples is then calculated using the formula: Absorbance = (A 510nm pH 1.0 − A 700nm pH 1.0) − (A 510nm pH 4.5 − A 700nm pH 4.5). Finally the % w/w of total anthocyanins in the sample is calculated by using the formula: % w/w Anthocyanins = A/εL × MW × DF × V/Wt × 100% where A = Absorbance; ε = cyanidin-3-glucoside molar absorbance (26,900); MW = anthocyanin molecular weight (449.2 g/L); DF = dilution factor; V = final volume (mL); Wt = sample weight (mg); L = cell path length (1 cm). JFE contained 3.6% anthocyanins as cyanidin-3-glucoside equivalents.
High Performance Liquid Chromatography (HPLC-UV)
All HPLC analyses were conducted on a Shimadzu LC-10AS pump with a photodiode array (PDA)-UV-VIS detector and operated by Class VP version 4.2 software. All samples (20 µL injection volume; 10 mg/mL concentrations) were filtered (0.22 µM) and analyzed on a Luna C-18 column (Phenomenex; 250 × 4.6 mm i.d., 5µ). The mobile phase, solvent A: 3.5% aqueous phosphoric acid, and solvent B: acetonitrile; Gradient %A: intial: 95%, 10 min: 90%, 20 min: 87%, 30 min: 82%, 35 min: 75%, 40 min: 40%, 41 min: 95%; run time 61 min; flow rate 0.75 mL/min; anthocyanins were monitored at 530 nm.
Liquid Chromatography Mass Spectrometry (LC-MS)
All LC-MS analyses were carried out on a Q-Star Elite (Applied Biosystems MDS) time of flight (TOF) mass spectrometer equipped with a Turbo Ionspray source and coupled to an HP 1100 series HPLC system consisting of an autosampler/injector, quaternary pump, and diode array (DAD) detector. Data handling was carried out using Analyst QS version 2.0 software (Applied Biosystems). Conditions for detection of anthocyanins were as follows: Column: XBridge C18, 100 mm × 4.5 i.d., 5 µm, (Waters Corp., Milford, MA); Solvent A: 1% aqueous formic acid; solvent B:1% formic acid in methanol ; Gradient % A: intial: 95%, 5 min: 95%, 15 min: 90%, 60 min: 80%, 65 min: 80%, 67 min: 95%, 80 min: 95%; run time: 80 min; flow rate: 0.15 mL/min; injection volume: 20 µL; column temperature: 30°C; DAD range: 210-600 nm, 530 as detection wavelength for anthocyanins. MS parameters: Ionization mode ESI+; scan range: 400-1000 amu; scan rate: 1 scan/sec. Peak identities were obtained by matching their molecular M + and MS/MS ions as shown in Table 1 and Figure 2 and by comparison to literature data (11, 12) .
Cell Culture Materials
The breast cell lines, MCF-7, MDA-MB-231 and MCF10, were obtained from the American Type Culture Collection (ATCC) (Rockville, MD). The MCF-7aro cells were prepared from MCF-7 by transfection with human CYP19 (MCF-7aro) as previously reported (2). The different cell lines were cultured in their ATCC recommended media as follows. The MCF-7 cells were cultured in Eagle's minimum essential medium (MEM) (Invitrogen, Grand Island, NY) supplemented with 10% fetal bovine serum (FBS) and the antibiotic G418 (500 µg/mL) (UBS Corporation, Cleveland, OH). MCF-7aro cells were cultured in Eagle's MEM with Earle's salts, 1 mmol/L pyruvate, 2 mmol/L glutamine (Irvine Scientific, Santa Ana, CA), and 10% heat-inactivated FCS (ΔFCS; Omega Scientific, Tarzana, CA). MCF-10A cells were cultured in 50:50 DMEM/HAM's F-12 supplemented with 10% horse serum, 2 µmol/L insulin, 0.5 mg/L hydrocortisone, 20 µg/L epidermal growth factor, and 100 µg/L cholera toxin. MDA-MB-231 cells were cultured in RPMI-1640 supplemented with 10% ΔFCS. All cell lines were incubated in a humidified environment at 37 °C in 5% CO 2 and maintained in the linear phase of growth.
Cell Proliferation Assay
Proliferation was measured utilizing the CellTiter-Glo® Luminescent Cell Viability Assay (Technical Bulletin # 288, Promega Corp., Madison, WI) as previously reported (13) . When added to cells, the assay reagent produces luminescence in the presence of ATP from viable cells. Briefly, cells were plated in 96-well plates at a density of 5,000 cells/well and incubated for 24 hours. Test samples were solubilized in DMSO by sonication, filter sterilized, diluted with media to the desired treatment concentration and immediately used in the experiment. The final DMSO concentration per well did not exceed 0.3%. Cells were treated with 100 µL media or test samples and incubated for 24, 48 or 72 h sample exposure duration. JFE was tested at 0, 12.5, 25, 50, and 100 µg/mL concentrations. At the end of the 24, 48 or 72 h sample exposure duration, plates were equilibrated at room temperature for 30 min, 100 µL of the assay reagent was added to each well and cell-lysis was induced on an orbital shaker for 2 min. Plates were then incubated at room temperature for 10 min to stabilize the luminescence signal and results were read on an Orion Microplate Luminometer (Bertholds Detection Systems, Pforzheim, Germany). All plates had control wells containing medium without cells to obtain a value for background luminescence which was subtracted from the test sample readings. Three separate experiments were conducted and data are expressed as a ratio of treated to untreated cells, mean ±SE for three replications.
Assessment of Apoptosis
Apoptosis was assessed utilizing the Cell Death Detection ELISA PLUS Assay (Boehringer Mannheim, Indianapolis, IN) as previously reported (13) . This assay is a photometric enzymelinked immunoassay that quantitatively measures the internucleosomal degradation of DNA, which occurs during apoptosis. Specifically, the assay detects histone associated mono-and oligonucleosomes, which are indicators of apoptosis. Briefly, cells were plated in 60 mm dishes at a density of 250,000 cells/dish and allowed to attach for 24 h. Cells were then treated with media control or JFE at 100 or 200 µg/mL concentrations for 48 h. Following treatments, nonadherent cells were collected and pelleted at 200 × g for ten minutes. The supernatant was discarded and the cell pellet was washed with cold CMF-PBS and re-centrifuged. Adherent cells were washed with cold calcium magnesium free-phosphate buffered saline (CMF-PBS, 137 mmol/L sodium chloride, 1.5 mmol/L potassium phosphate, 7.2 mmol/L sodium phosphate, 2.7 mmol/L potassium chloride, pH 7.4), trypsinized, collected and combined with non-adherent cells into a total of 1 mL DMEM. Both live and dead cells were then counted via trypan blue exclusion (Pierce, Rockford, IL), equal numbers of cells were added to the microtiter plate for all treatment groups, and the apoptosis assay was performed according to the manufacturer's instructions. Data are expressed as absorbance at 405 nm of each sample over vehicle controls.
Statistical Analysis
Data were analyzed by either student's t-test, one-way ANOVA followed by Dunnett's Multiple Range test (α= 0.05) or two-way ANOVA with Graph Pad Prism 3.0 (Graph Pad Software Inc.) as appropriate.
RESULTS AND DISCUSSION
Phytochemical Studies on Jamun Fruit Extract (JFE)
Although JFE may contain a wide diversity of phytochemical constituents, in the current study, JFE was standardized to anthocyanin content (3.5% anthocyanins, as cyanidin-3-glucoside equivalents) using the pH differential method. Anthocyanin-rich extracts are frequently standardized to cyanidin-3-glucoside equivalents by both research (10, 14) and industrial laboratories (see NSF, an independent non-profit third-party certification provider: www.nsf.org). This is because of the historical usage of cyanidin-3-glucoside for similar assays and its wide commercial availability. The use of a common accepted standard to quote anthocyanin content is pertinent, considering that many fruits, vegetables and derived food products contain a mixture of several anthocyanins (12) .
Five anthocyanins were detected in JFE by using HPLC-UV analyses and their relative proportions in order of increasing HPLC retention times (t R ) were peak 3 (t R 27.2 min) > peak 5 (t R 31.9 min) > peak 1 (t R 22.4 min) > peak 2 (t R 25.4 min) > peak 4 (t R 30.7 min) (see Figure  2A ). The anthocyanins were then identified by LC-MS/MS analyses from the mass/charge (m/ z) ratios of their molecular ions (M + ) and of their MS/MS product ions as follows: peak 1=delphinidin-diglucoside (627;465/303); peak 2=cyanidin-diglucoside (611;449/287); peak 3=petunidin-diglucoside (641;479/317), peak 4=peonidin-diglucoside (625;463/301), and peak 5=malvidin-diglucoside (655;493/331) (see Figure 2B and Table 1 ). This is in agreement with a previous report for E. jambolana fruits collected in Brazil (11) . In that study, of several tropical fruits analyzed for anthocyanin content, Jamun berries displayed the widest variability in aglycone structure (11) . Anthocyanins from fruits typically display patterns of either having different aglycones present with matching sugar patterns, as in the case of Jamun berries, or a single dominant aglycone with other minor anthocyanin components present (12) .
There is disagreement in the literature about the point(s) of attachment for the dissacharose units of anthocyanins from E. jambolana fruit as being either on the 3 and 5 positions (i.e. as 3,5-diglucosides), as reported by de Brito et al (11) , or on the 3-postion alone (as gentiobiose and laminaribiose), as reported by Jain and Seshadri (15) . It should be noted that without authentic anthocyanin standards, whose structures have been unequivocally identified by proton and/or carbon-13 nuclear magnetic resonance ( 1 H and 13 C-NMR) spectrometry, the utilization of HPLC-UV and LC-MS/MS techniques cannot determine the points of attachment of the disaccharide units to anthocyanidin/aglycon unit. To this end, our laboratory is currently pursuing the isolation and structural elucidation (using NMR methods) of the individual anthocyanins present in the JFE used in our study. In addition, further studies to identify other phytochemical constituents (non-anthocyanin phenolics and non-phenolics) present in JFE, which may contribute towards its observed biological activities, are necessary.
There are also differences reported for anthocyanin profiles in E. jambolana fruits collected from different geographical regions. For example, the fruits used in the current study had a similar 'five anthocyanin profile' to those collected in Brazil (11) , but are different from those collected in Egypt (16) . In that study, fruits collected from Egypt had a 'four anthocyanin profile' consisting of pelargonidin-3-glucoside, pelargonidin-3,5-diglucoside, cyanidin-3malonyl-glucoside and delphinidin-3-glucoside (16) . It is not unusual for fruits collected from different geographical locations to have different phytochemical profiles. Indeed, the anthocyanidins present in the Jamun berries in our study were in the order of relative proportion of petunidin>malvidin>delphinidn>cyanidin>peonidin while the Brazilian berries had delphinidin>petunidin>malvidin>cyanidin>peonidin (11) . This highlights the importance of utilizing well-characterized and standardized materials for biological studies since their bioactivities may differ tremendously based on their phytochemical profile and individual constituents. Future studies to identify the anthocyanins present in E. jamoblana fruits collected from different countries are currently being pursued in our laboratory.
Antiproliferative Effects of Jamun Fruit Extract (JFE)
JFE was tested against all cell lines at concentrations ranging from 0-100 µg/mL at three different time points of 24, 48 and 72 h. The anti-proliferative bioassay showed that JFE significantly inhibited the growth of both the MCF-7aro ( Fig. 3B ) and MDA-MB-231 ( Fig.  3C ) breast cancer cells in both dose and time dependent manner. The concentrations required to inhibit the growth of 50% of the cells, i.e. IC 50 values were calculated for the different cell lines at the 72 h time point. The IC 50 values were 27 µg/mL for the MCF-7aro and 40 µg/mL for the MDA-MB-231 breast cancer cells. It is noteworthy that JFE was less effective at reducing the proliferation of the normal MCF-10A cells (Fig. 3A) with IC 50 ≥ 100 µg/mL, indicating a specific action on the tumorigenic cell lines. In the current antiproliferative bioassays, we found that JFE was most effective against the estrogen receptor (ER) positive MCF7aro breast cancer cells, compared to the triple negative MDA-MB-231 breast cancer cells. However, further experiments to investigate the mechanisms of anti-proliferative actions of JFE components in breast cancer should be conducted. In addition, whether JFE shows greatest potential against breast cancer compared to other types of cancer cells should be explored. Previous research has shown that a Jamun fruit extract exhibited the most potent cytotoxic activity against MCF7 breast carcinoma cells (IC 50 =5.9 µg/mL), compared to other cancer cell lines such as the Hela cervix carcinoma cell line, HEPG2 liver carcinoma cell line, H460 lung carcinoma cell line, and U251 brain carcinoma cell line, (IC 50 >10 µg/mL) (16) .
Pro-Apoptotic Effects of Jamun Fruit Extract (JFE)
The results from the apoptosis study showed no induction of cell death in the MCF-10A line, indicating that JFE is non-toxic to this untransformed cell line as opposed to its pro-apoptotic effect in the two breast cancer cell lines. Although the MCF-7aro cells appeared to be more sensitive to the effects of JFE, the difference in the levels of apoptosis between these two cell lines was not significant.
The limitations of the current study should be taken into context since the JFE levels used in the above cell culture studies may far exceed levels of phenolics and/or their metabolites achievable physiologically. Neverthelesss, our results provide preliminary data as to the ability of JFE to inhibit the growth and induce apoptosis of human breast cancer cell lines in vitro.
The results from the current study warrant further investigation into the potential of E. jambolana berries, and its derived food products, as chemopreventive agents against breast cancer. In addition, our future studies will investigate the possible bioactive components of JFE and their mechanisms of action against the proliferation and survival of breast cancer cell lines. HPLC-UV chromatogram of Jamun Fruit Extract (JFE) at 520 nm. Anthocyanins were identified as delphinidin-diglucoside (peak 1, t R =22.4 min), cyanidin-diglucoside (peak 2, t R =25.4 min), petunidin-diglucoside (peak 3, t R =27.2), peonidin-diglucoside (peak 4, t R =30.7 min), and malvidin-diglucoside (peak 5, t R =31.9 min). Figure 2B Antiproliferative activities of JFE against 3A: MCF10A (untransformed/non-tumorigenic) breast cells, 3B: MDA-MB-231 (estrogen independent) breast cancer cells and 3C: MCF7aro (estrogen dependent/aromatase positive) breast cancer cells. Cells were exposed to JFE at concentrations ranging from 0-100 µg/mL for 24, 48 or 72 h. Proliferation was measured via the CellTiter-Glo® Luminescent Cell Viability Assay. Data are expressed as percentage of untreated cells, mean ±SE and analyzed utilizing One-Way ANOVA followed by Dunnet's Multiple Range test. Asterisk indicates a significant difference compared to untreated controls (p≤0.01). 
